Pfizer Recalling 3 Blood Pressure Medication Types Due To Cancer Concerns, FDA Says

This time the culprit is a nitrosamine, N-nitroso-quinapril, being present in quantities above Acceptable Daily Intake (ADI) levels.

Source: Forbes.com Healthcare News - March 26, 2022 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news